Hugel Achieves Record-High Revenue and Operating Profit

– Achieved 4Q revenue of KRW 88.9bn, operating profit of KRW 36.8bn, net profit of KRW 17.1bn, respectively 4%, 22.4%, 451.6% YoY growth

– FY 23 Sales growth of 5.2% and 25.1% for botulinum toxin and HA filler, with growth in domestic and international markets

SEOUL, South Korea, Feb. 14, 2024 /PRNewswire/ — Hugel, a global total medical aesthetics company, announced its 4Q 23 consolidated financial results on the 14th, reporting revenue of KRW 88.9 billion, operating profit of KRW 36.8 billion, and net profit of KRW 17.1billion, achieving another quarterly record-high. Sales revenue, operating profit, and net profit grew by 4%, 22.4%, and 451.6%, respectively, YoY.

Full story available on Benzinga.com